Medivation, Pfizer Disappointed Over Drug Failure - Biotech's Latest - Seekingalpha.com
Medivation, Pfizer Disappointed Over Drug Failure - Biotech's Latest - Seekingalpha.com
Pfizer ( PFE ) and Medivation ( MDVN ) said dimebon, their experimental drug to treat Alzheimer’s disease, failed in two late-stage clinical trials. Medivation’s stock, which
U.S. Stocks Etch New Session Highs - Investors Business Daily
Volume was tracking higher across the board. Meanwhile, the Dow and NYSE composite rose 0.2% each while the NYSE composite edged up a fraction. UAL Corp. ( UAUA ) jumped 8% to a
Pfizer ( PFE ) and Medivation ( MDVN ) said dimebon, their experimental drug to treat Alzheimer’s disease, failed in two late-stage clinical trials. Medivation’s stock, which
U.S. Stocks Etch New Session Highs - Investors Business Daily
Volume was tracking higher across the board. Meanwhile, the Dow and NYSE composite rose 0.2% each while the NYSE composite edged up a fraction. UAL Corp. ( UAUA ) jumped 8% to a
<< Home